Equitec Proprietary Markets’s Bristol-Myers Squibb BMY Stock Holding History

Equitec Proprietary Markets’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,300	Closed	-$81K	–	282
2021 Q4	$81K	Buy	+1,300	New	+$76.3K	0.01%	175
2020 Q4	$6K	Buy	+100	New	+$6.15K	﹤0.01%	113
2015 Q1	–	Sell	-14,975	Closed	-$884K	–	205
2014 Q4	$884K	Buy	+14,975	New	+$845K	0.04%	106

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Equitec Proprietary Markets's BMY Position: Q1 2022 in Review

Equitec Proprietary Markets sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 1,300 shares — an estimated $81K sold.

Equitec Proprietary Markets first reported a position in BMY in Q4 2014 and held it in 3 quarters. The position peaked at $884K in Q4 2014. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

Equitec Proprietary Markets reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
Equitec Proprietary Markets sold 1,300 Bristol-Myers Squibb shares in Q1 2022, an estimated $81K.
Equitec Proprietary Markets first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 3 quarters.
Equitec Proprietary Markets's Bristol-Myers Squibb position peaked at $884K in Q4 2014.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Equitec Proprietary Markets's 13F filing for Q1 2022, filed 22 Apr 2022.